Helin Feng

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Inferior Vena Cava

Anterior Cruciate Ligament Reconstruction

Long Non Coding Rna

Top Venues

The Journal of international medical research

Cell death discovery

Analytical cellular pathology (Amsterdam)

This page only lists publications with an associated author ORCID identifier.

Publications

Jiazheng Zhao, Ning Zhang, Xiaowei Ma, Ming Li, Helin Feng
The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity. Cell death discovery 9 (1) (2023)
Jiazheng Zhao, Yi Zhao, Xiaowei Ma, Helin Feng, Rongmin Cui
Immunological and prognostic significance of novel ferroptosis-related genes in soft tissue sarcoma. PloS one 17 (1) (2022)
Shivendra Singh, Ahmed Abu-Zaid, Hongjian Jin, Jie Fang, Qiong Wu, Tingting Wang, Helin Feng, Waise Quarni, Ying Shao, Lily Maxham, Alireza Abdolvahabi, Mi-Kyung Yun, Sivaraja Vaithiyalingam, Haiyan Tan, John Bowling, Victoria Honnell, Brandon M Young, Yian Guo, Richa Bajpai, Shondra M Pruett-Miller, Gerard C Grosveld, Mark E Hatley, Bei-Si Xu, Yiping Fan, Gang Wu, Eleanor Y Chen, Taosheng Chen, Peter W Lewis, Zoran Rankovic, Yimei Li, Andrew Jackson Murphy, John Easton, Junmin Peng, Xiang Chen, Ruoning Wang, Stephen W White, Andrew M Davidoff, Jun J Yang
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma. Science translational medicine 14 (653) (2022)
Yi Zhao, Qianqian Zhang, Helin Feng, Xiyan Zhu
Oesophageal carcinoma with solitary patellar metastasis: a rare case report. The Journal of international medical research 49 (4) (2021)
Hongzeng Wu, Qianqian Zhang, Yi Zhao, Fengzhou Xu, Jinming Zhang, Hongyan He, Xu Wang, Helin Feng
Association of sirtuin-1 and vascular endothelial growth factor expression with tumor progression and poor prognosis in liposarcoma. The Journal of international medical research 48 (6) (2021)
Xujian Liu, Qianqian Zhang, Yi Zhao, Jianjun Xun, Hongzeng Wu, Helin Feng
Association of JMJD2B and Hypoxia-Inducible Factor 1 Expressions with Poor Prognosis in Osteosarcoma. Analytical cellular pathology (Amsterdam) 2020 (2020)